Archives: Agenda

The clinical research industry is at an inflection point. Advancements in technology have created the opportunity to transform clinical trial outcomes, but to make this ambition a reality, we must now rethink how we engage with patients.

Today, we often treat patient relationships as transactional, de-identified numbers on individual clinical trials. We need a new way of thinking about patients. A more longitudinal way, with greater pre-trial engagement and post-trial follow-up, and across multiple studies and healthcare experiences.

We also need to change how we look at patient data, widening the lens to understand patients’ health and research journeys across a broad ecosystem of data sources. But how do we execute this paradigm shift when we’re also under pressure to accelerate timelines, reduce risk, lower costs, and improve quality?

In this presentation, we’ll explore:

• Industry drivers of this clinical research evolution
• Challenges faced & the value of change
• Reasons to believe – Improving trial experiences for patients, sites, CROs, & sponsors

• Maximizing the opportunity for strategic input and design feedback from your CRO throughout the outsourcing process
• Overview of the typical areas where your CRO can guide and facilitate study optimization
• Examples of where CRO experience has transformed study design and operations, to sponsor advantage

• Understanding regulation and preparing compliance
• Driving innovation and technology into processes through use of generative AI
• Implementing AI for practical use with valuable return on investment

• Establishing common ground with your CRO
• Ascertaining the critical factors to think about when you collaborate with a CRO
• Exploring how the concept of co-development between Pharma & CRO is working best
• Overcoming the differences between Pharma & CRO business models to work in harmony
• Underlining the factors which could be limiting what choice you make?